Amy James

Frederick National Laboratory for Cancer Research

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2”.

The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-1064

N/A

0DataRank · unranked

15 citations

Yilun Sun, Shar-yin N. Huang, Amy James, Simone Difilippantonio, Yves Pommier +1 more

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1646

N/A

0DataRank · unranked

21 citations

Xiaolin Wan, Jacob S. Roth, David J. Liewehr, Nancy E. Sealover, William J.E. Frye +29 more

3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor

Journal of Translational Medicine(2022)10.1186/s12967-022-03580-8

N/A

0DataRank · unranked

5 citations

Joseph D. Kalen, Paula Jacobs, Lisa Riffle, Amy James, Lai Thang +6 more

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02667-4

N/A

0DataRank · unranked

20 citations

Laura S. Schmidt, Kelli M. Wilson, Christopher J. Ricketts, Carole Sourbier, Cathy D. Vocke +23 more

Toward a CRISPR-based mouse model of Vhl -deficient clear cell kidney cancer: Initial experience and lessons learned

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2408549121

N/A

0DataRank · unranked

10 citations

Wenhua Gao, Laura S. Schmidt, Kevin Bi, C. Ricketts, Vijyendra Ramesh +28 more

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-24-0225

N/A

0DataRank · unranked

8 citations

Christopher J. Ricketts, Laura S. Schmidt, Julia I. Medina, Keita Saito, Lilia Ileva +25 more

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

Cancers(2024)10.3390/cancers16132320

N/A

0DataRank · unranked

6 citations

Jacob S. Roth, Edjay R. Hernandez, Joshua T. Kowalczyk, Nancy E. Sealover, Katie E. Hebron +17 more

Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumors

Science Signaling(2025)10.1126/scisignal.ado2857

N/A

0DataRank · unranked

9 citations

Meghri Katerji, Marwa M. Afifi, Katherine M. Nyswaner, Carolyn C. Woodroofe, Zoe C. Edwards +22 more